880 - 580 HORNBY STREET, VANCOUVER, A1
Announces Leadership Update
Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function.
Appoints Kim Remizowski to Board of Directors as Independent Director
Announces Annual General Meeting Details
Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
Condensed Interim Consolidated Financial Statements
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Amended Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Notice of Exempt Offering of Securities
No filings found
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Correspondence
Submission Upload
Supplemental Filing
Free Writing Prospectus